louisakewell, Author at European Medical Journal - Page 131 of 153

How I Treat: Prostate Cancer With Minimally Invasive Techniques

Currently, 17-35% of newly diagnosed cases of prostate cancer (PrC) are classified as high-risk. This group of patients has the highest rate of…

EMJ

THSD7A: Another Hope for Membranous Nephropathy Sufferers

IDENTIFICATION of a protein, thrombospondin type-1 domain-containing protein 7A (THSD7A), that turns a person’s immune system against itself in…

EMJ

Stem Cells: The Cellular Origins of Fibrosis

POTENTIAL culprits that give rise to chronic tissue scarring, which can lead to the development of fibrosis, have been identified as a rare population of…

EMJ

Artificial Liver Leads the Way as New Life-Saver

BIOARTIFICIAL livers could possess the ability to sustain liver failure (LF) patients until their own internal organs can repair themselves or…

EMJ

Could New Cure Conquer Crohn’s in 2015?

SUFFERERS of Crohn’s disease (CrD) worldwide could potentially be one step away from reaping the benefits of a cure for their condition, changing lives…

EMJ

Liver Cancer Menace May Lie in Surrounding Immunity

MACROPHAGES may constitute the next target for liver cancer treatment as the presence of epidermal growth factor receptor (EGFR) in the cells…

EMJ

Gene Culprit behind Metabolic Syndrome Revealed

HEALTHY gut microbiota may be the key to tackling metabolic syndrome (MetS); when a particular gene, known as Toll-like receptor 5 (TLR5), is…

EMJ

New Oncotype DX® Data Presented at 2014 San Antonio Breast Cancer Symposium Further Demonstrate the Practice-Changing Impact of the Test in Guiding the Treatment of Early Stage Breast Cancer

GENEVA, Switzerland, [December 15, 2014] – Genomic Health announced presentation of the first prospective outcomes data from a large adjuvant study…

Case Reports and Literature Review of Genital Psoriasis: Successful Therapy with Tacrolimus

Psoriasis is a chronic, inflammatory skin disease with a high prevalence in the general population. However, though psoriasis may involve all sites of…

EMJ

Gilead Presents Follow-Up Data from Idelalisib (Zydelig®) Registrational Studies in Patients with Chronic Lymphocytic Leukemia, Follicular Lymphoma and Small Lymphocytic Lymphoma

San Francisco, December 10, 2014 – Gilead Sciences, Inc. (Nasdaq: GILD) today announced long-term follow-up results from the registration studies…